Methods of Assessing a Risk of Cancer Progression

Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.

Patents:
WO 2,011,014,697

Inventor(s): WEISS GLEN [US]; KIM SEUNGCHAN [US]; NASSER SARA [US]

Type of Offer: Licensing



« More Biotech Patents

Share on      


CrowdSell Your Patent